相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diabetes: a driver for heart failure
Adriaan A. Voors et al.
HEART (2011)
Effects of Anti-VEGF on Predicted Antibody Biodistribution: Roles of Vascular Volume, Interstitial Volume, and Blood Flow
C. Andrew Boswell et al.
PLOS ONE (2011)
Activation of adenosine A2A receptors restores the altered cell-cycle machinery during impaired wound healing in genetically diabetic mice
Domenica Altavilla et al.
SURGERY (2011)
Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials
Remy Boussageon et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
Mitomu Kioi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Membrane receptors: Structure and function of the relaxin family peptide receptors
Roy C. K. Kong et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Scar Prevention and Cosmetically Enhanced Wound Healing Using Relaxin
Dennis R. Stewart
RELAXIN AND RELATED PEPTIDES: FIFTH INTERNATIONAL CONFERENCE (2009)
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study
John R. Teerlink et al.
LANCET (2009)
Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player
Dietmar Vestweber et al.
TRENDS IN CELL BIOLOGY (2009)
Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse
Mariarosaria Galeano et al.
WOUND REPAIR AND REGENERATION (2008)
Recombinant human erythyopoietin improves angiogenesis and wound healing in experimental burn wounds
M Galeano et al.
CRITICAL CARE MEDICINE (2006)
The effect of relaxin treatment on skeletal muscle injuries
S Negishi et al.
AMERICAN JOURNAL OF SPORTS MEDICINE (2005)
Wound healing and its impairment in the diabetic foot
V Falanga
LANCET (2005)
Relaxin: Antifibrotic Properties and Effects in Models of Disease
Chrishan S. Samuel
CLINICAL MEDICINE & RESEARCH (2005)
The biology of vascular endothelial growth factors
T Tammela et al.
CARDIOVASCULAR RESEARCH (2005)
Preventing foot ulcers in patients with diabetes
N Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Relaxin inhibits the activation of human neutrophils: Involvement of the nitric oxide pathway
E Masini et al.
ENDOCRINOLOGY (2004)
Endothelial progenitor cells - Functional characterization
C Urbich et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2004)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse
M Galeano et al.
DIABETOLOGIA (2003)
Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo
EJ Williams et al.
GUT (2001)
Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse
D Altavilla et al.
DIABETES (2001)
Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse:: Prolonged persistence of neutrophils and macrophages during the late phase of repair
C Wetzler et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites
EN Unemori et al.
WOUND REPAIR AND REGENERATION (2000)
分享论文
